Posters (Abstracts 289–2348)
1 October 2019
1 October 2019
1 October 2019
In the first part of the webinar, we will provide an overview regarding the definitions of acute-on-chronic liver failure and the management of the cirrhotic patient with multi-organ system failure.
Yunhuan Liu, Kefei Chen, Fengyuan Li, Zelin Gu, Qi Liu, Liqing He, Tuo Shao, Qing Song, Fenxia Zhu, Lihua Zhang, Mengwei Jiang, Yun Zhou, Shirish Barve, Xiang Zhang, Craig J. McClain, Wenke Feng – 30 September 2019
Amir Almasi‐Hashiani, Mohammad Ali Mansournia – 30 September 2019
Christian Labenz, Jürgen H. Prochaska, Yvonne Huber, Michael Nagel, Beate K. Straub, Philipp Wild, Peter R. Galle, Jörn M. Schattenberg – 30 September 2019 – Cardiovascular disease (CVD) is the leading cause of death in patients with nonalcoholic fatty liver disease (NAFLD). The current analysis expands the knowledge on atherogenic lipid profiles in NAFLD by modeling changes in low‐density lipoprotein cholesterol (LDL‐C) and total cholesterol (TC) in a prospectively enrolling real‐life study cohort to inform physicians on the cardiovascular (CV) event risk based on these changes.
Sung‐Hsi Huang, Chia‐Jui Yang, Chien‐Ching Hung – 30 September 2019
Domitille Erard‐Poinsot, Sébastien Dharancy, Marie‐Noëlle Hilleret, Stéphanie Faure, Géraldine Lamblin, Christine Chambon‐Augoyard, Hélène Donnadieu‐Rigole, Guillaume Lassailly, Olivier Boillot, José Ursic‐Bedoya, Olivier Guillaud, Vincent Leroy, Georges‐Philippe Pageaux, Jérôme Dumortier – 28 September 2019 – Alcohol‐related liver disease (ALD) is one of the main indications for liver transplantation (LT). Severe alcohol relapse can rapidly lead to recurrent alcohol‐related cirrhosis (RAC) for the graft.
Carlos Jiménez‐Romero, Alejandro Manrique, María García‐Conde, Anisa Nutu, Jorge Calvo, Óscar Caso, Alberto Marcacuzco, Álvaro García‐Sesma, Edurne Álvaro, Roberto Villar, José María Aguado, María Conde, Iago Justo – 28 September 2019 – The utilization of livers from donation after uncontrolled circulatory death (uDCD) increases the availability of liver grafts, but it is associated with a higher incidence of biliary complications (BCs) and lower graft survival than those organs donated after brain death.